Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in spontaneous lymphoblastoid cell lines.

MLA

Tam, Kam Pui, et al. “Combination of Bortezomib and Venetoclax Targets the Pro-Survival Function of LMP-1 and EBNA-3C of Epstein-Barr Virus in Spontaneous Lymphoblastoid Cell Lines.” PLoS Pathogens, vol. 20, no. 9, Sept. 2024, pp. 1–24. EBSCOhost, https://doi.org/10.1371/journal.ppat.1012250.

APA

Tam, K. P., Xie, J., Au-Yeung, R. K. H., & Chiang, A. K. S. (2024). Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in spontaneous lymphoblastoid cell lines. PLoS Pathogens, 20(9), 1–24. https://doi.org/10.1371/journal.ppat.1012250

Chicago

Tam, Kam Pui, Jia Xie, Rex Kwok Him Au-Yeung, and Alan K. S. Chiang. 2024. “Combination of Bortezomib and Venetoclax Targets the Pro-Survival Function of LMP-1 and EBNA-3C of Epstein-Barr Virus in Spontaneous Lymphoblastoid Cell Lines.” PLoS Pathogens 20 (9): 1–24. doi:10.1371/journal.ppat.1012250.